Abstract
Gallstone disease is one of the most costly digestive diseases requiring hospitalization in westernized countries, and its prevalence ranges from 10% to 15% in adults in Europe and the USA [1–4]. The burden of disease is summarized by the prevalence of patients with gallstones, by its incidence (over a million new diagnoses of gallstones a year), and by the number of cholecystectomies performed yearly in the USA (approaching 700,000) [5]. Similar trends in gallstone disease have been confirmed in large epidemiological surveys carried out in Italy [6–10]. In Western societies approximately 80% of gallstones are cholesterol gallstones [11], either pure cholesterol or mixed cholesterol stones (containing more than 50% cholesterol by weight).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Portincasa P, Moschetta A, Palasciano G (2006) Cholesterol gallstone disease. Lancet 368:230–239
Wang DQH, Afdhal NH (2004) Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes. Curr Gastroenterol Rep 6:140–150
Everhart JE, Khare M, Hill M et al (1999) Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 117:632–639
Sandler RS, Everhart JE, Donowitz M et al (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122:1500–1511
National Institutes of Health (1993) Consensus Development Conference Statement on Gallstones and Laparoscopic Cholecystectomy. Am J Surg 165:390–398
Attili AF, De Santis A, Capri R et al (1995) The natural history of gallstones: the GREPCO experience. Hepatology 21:656–660
Attili AF, Carulli N, Roda E et al (1995) Epidemiology of gallstone disease in Italy: prevalence data of the Multicepter Italian Study on Cholelithiasis (M.I.C.O.L.). Am J Epidemiol 141:158–165
Attili AF, Capocaccia R, Carulli N et al (1997) Factors associated with gallstone disease in the MICOL experience. Hepatology 26:809–818
Attili AF, Scafato E, Marchioli R et al (1998) Diet and gallstones in Italy: the cross-sectional MICOL results. Hepatology 27:1492–1498
Festi D, Sottili S, Colecchia A et al (1999) Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL). Hepatology 30:839–846
Diehl AK (1991) Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 20:1–19
Grundy SM (2004) Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr 80:1–2
Wang DQH, Zhang L, Wang HH (2005) High cholesterol absorption efficiency and rapid biliary secretion of chylomicron remnant cholesterol enhance cholelithogenesis in gallstone-susceptible mice. Biochim Biophys Acta 1733:90–99
Lammert F, Sauerbruch T (2005) Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2:423–433
Sherlock S, Dooley J (2002) Diseases of the liver and biliary system. Blackwell Science, Oxford
Portincasa P, Moschetta A, Mazzone A et al (2003) Water handling and aquaporins in bile formation: recent advances and research trends. J Hepatol 39:864–874
Groen AK, Bloks VW, Bandsma RH et al (2001) Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. J Clin Invest 108:843–850
Grunhage F, Lammert F (2006) Gallstone disease. Pathogenesis of gallstones: a genetic perspective. Best Pract Res Clin Gastroenterol 20:997–1015
Berge KE, Tian H, Graf GA et al (2000) Accumulation of dietary cholesterol in cytosterolemia caused by mutations in adjacent ABC transporters. Science 290:1771–1775
Lee MH, Lu K, Hazard S et al (2001) Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27:79–83
Smit JJM, Schinkel AH, Oude Elferink RPJ et al (1993) Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451–462
Bodzioch M, Orso E, Klucken J et al (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347–351
Rust S, Rosier M, Funke H et al (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352–355
Brooks-Wilson A, Marcil M, Clee SM et al (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22:336–345
de Vree JM, Jacquemin E, Sturm E et al (1998) Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 95:282–287
Deleuze JF, Jacquemin E, Dubuisson C et al (1996) Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 23:904–908
Dixon PH, Weerasekera N, Linton KJ et al (2000) Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 9:1209–1217
Strautnieks SS, Bull LN, Knisely AS et al (1998) A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 20:233–238
Lee MH, Lu K, Hazard S et al (2001) Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27:79–83
Graf GA, Yu L, Li WP et al (2003) ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J Biol Chem 278:48275–48282
Kosters A, Kunne C, Looije N et al (2006) The mechanism of ABCG5/ABCG8 in biliary cholesterol secretion in mice. J Lipid Res 47:1959–1966
Wang HH, Patel SB, Carey MC et al (2007) Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(-l-) mice. Hepatology 45:998–1006
Yu L, Li-Hawkins J, Hammer RE et al (2002) Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110:671–680
Yu L, Hammer RE, Li-Hawkins J et al (2002) Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 99:16237–16242
Gerloff T, Stieger B, Hagenbuch B et al (1998) The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 273:10046–10050
Wang R, Salem M, Yousef IM et al (2001) Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci USA 98:2011–2016
Wang R, Lam P, Liu L et al (2003) Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P-glycoprotein. Hepatology 38:1489–1499
de Vree JM, Jacquemin E, Sturm E et al (1998) Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 95:282–287
van Erpecum KJ, Carey MC (1997) Influence of bile salts on molecular interactions between sphingomyelin and cholesterol: relevance to bile formation and stability. Biochim Biophys Acta 1345:269–282
Wang H, Chen J, Hollister K et al (1999) Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3:543–553
Makishima M, Okamoto AY, Repa JJ et al (1999) Identification of a nuclear receptor for bile acids. Science 284:1362–1365
Parks DJ, Blanchard SG, Bledsoe RK et al (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365–1368
Janowski BA, Willy PJ, Devi TR et al (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383:728–731
Zhang Z, Li D, Blanchard DE et al (2001) Key regulatory oxysterols in liver: analysis as delta4-3-ketone derivatives by HPLC and response to physiological perturbations. J Lipid Res 42:649–658
Ananthanarayanan M, Balasubramanian N, Makishima M et al (2001) Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 276:28857–28865
Huang L, Zhao A, Lew JL et al (2003) Farnesoid X-receptor activates transcription of the phospholipid pump MDR3. J Biol Chem 278:51085–51090
Repa JJ, Berge KE, Pomajzl C et al (2002) Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277:18793–18800
Modica S, Moschetta A (2006) Nuclear bile acid receptor FXR as pharmacological target: are we there yet? FEBS Lett 580:5492–5499
Willy PJ, Mangelsdorf DJ () Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev 11:289–298
del Castillo-Olivares A, Gil G (2000) Role of FXR and FTF in bile acid-mediated suppression of cholesterol 7alpha-hydroxylase transcription. Nucl Acids Res 28:3587–3593
Lu TT, Makishima M, Repa JJ et al (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507–515
Peet DJ, Turley SD, Ma W et al (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93:693–704
Carey MC, Small DM (1978) The physical chemistry of cholesterol solubility in bile. Relation to gallstone formation and dissolution in man. J Clin Invest 61:998–1026
Holzbach RT, Marsh M, Olszewski M et al (1973) Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest 52:1467–1479
Mazer NA, Carey MC, Kwasnick RF et al (1979) Quasielastic light scattering studies of aqueous biliary lipid systems. Size, shape, and thermodynamics of bile salt micelles. Biochemistry 18:3064–3075
Mazer NA, Benedek GB, Carey MC (1980) Quasielastic light-scattering studies of aqueous biliary lipid systems. Mixed micelle formation in bile salt-lecithin solutions. Biochemistry 19:601–615
Mazer NA, Carey MC (1983) Quasi-elastic light-scattering studies of aqueous biliary lipid systems. Cholesterol solubilization and precipitation in model bile solutions. Biochemistry 22:426–442
Mazer NA, Schurtenberg P, Carey MC et al (1984) Quasi-elastic light scattering studies of native hepatic bile from the dog: comparison with aggregative behavior of model biliary lipid systems. Biochemistry 23:1994–2005
Somjen GJ, Gilat T (1983) A non-micellar mode of cholesterol transport in human bile. FEBS Lett 156:265–268
Somjen GJ, Gilat T (1985) Contribution of vesicular and micellar carriers to cholesterol transport in human bile. J Lipid Res 26:699–704
Somjen GJ, Marikovsky Y, Lelkes P et al (1986) Cholesterol-phospholipid vesicles in human bile: an ultrastructural study. Biochim Biophys Acta 879:14–21
Halpern Z, Dudley MA, Kibe A et al (1986) Rapid vesicle formation and aggregation in abnormal human biles: a time-lapse video-enhanced contrast microscopy study. Gastroenterology 90:875–885
Halpern Z, Dudley MA, Lynn MP et al (1986) Vesicle aggregation in model systems of supersaturated bile: relation to crystal nucleation and lipid composition of the vesicular phase. J Lipid Res 27:295–306
Holan KR, Holzbach RT, Hermann RE et al (1979) Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 77:611–617
Holzbach RT, Corbusier C (1978) Liquid crystals and cholesterol nucleation during equilibration in supersaturated bile analogs. Biochim Biophys Acta 528:436–444
Olszewski MF, Holzbach RT, Saupe A et al (1973) Liquid crystals in human bile. Nature 242:336–337
Wang DQH, Carey MC (1996) Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing system. J Lipid Res 37:606–630
Admirand WH, Small DM (1968) The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 47:1043–1052
Wang DQH, Carey MC (1996) Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences. J Lipid Res 37:2539–2549
Small DM, Bourges M, Dervichian DG (1966) Ternary and quaternary aqueous systems containing bile salt, lecithin, and cholesterol. Nature 211:816–818
Small DM, Bourges MC, Dervichian DG (1966) The biophysics of lipidic associations. I. The ternary systems: lecithin-bile salt-water. Biochim Biophys Acta 125:563–580
Small DM (1968) A classification of biologic lipids based upon their interaction in aqueous systems. J Am Oil Chem Soc 45:108–119
Small DM, Admirand W (1969) Solubility of bile salts. Nature 221:265–267
Hofmann AF, Amelsberg A, Vansonnenberg E (1993) Pathogenesis and treatment of gallstones. N Engl J Med 328:1854–1855
LaMont JT, Carey MC (1992) Cholesterol gallstone formation. 2. Pathobiology and pathomechanics. Prog Liver Dis 10:165–191
Wang DQH, Cohen DE, Lammert F et al (1999) No pathophysiologic relationship of soluble biliary proteins to cholesterol crystallization in human bile. J Lipid Res 40:415–425
Carey MC (1978) Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 19:945–955
Gollish SH, Burnstein MJ, Ilson RG et al (1983) Nucleation of cholesterol monohydrate crystals from hepatic and gallbladder bile of patients with cholesterol gallstones. Gut 24:836–844
Harvey PRC, Sömjen G, Lichtenberg MS et al (1987) Nucleation of cholesterol from vesicles isolated from bile of patients with and without cholesterol gallstones. Biochim Biophys Acta 921:198–204
Holzbach RT (1990) Current concepts of cholesterol transport and crystal formation in human bile. Hepatology 12:26S–31S
Holzbach RT (1990) Nucleation of cholesterol crystals in native bile. Hepatology 12:155S–161S
Wang DQH, Paigen B, Carey MC (1997) Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. J Lipid Res 38:1395–1411
Wang HH, Afdhal NH, Gendler SJ et al (2006) Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice. Gastroenterology 131:210–222
Konikoff FM, Chung DS, Donovan JM et al (1992) Filamentous, helical and tubular microstructures during cholesterol crystallization from bile. Evidence that biliary cholesterol does not nucleate classic monohydrate plates. J Clin Invest 90:1156–1161
Konikoff FM, Cohen DE, Carey MC (1994) Phospholipid molecular species influence crystal habits and transition sequences of metastable intermediates during cholesterol crystallization from bile salt-rich model bile. J Lipid Res 35:60–70
Konikoff FM, Laufer H, Messer G et al (1997) Monitoring cholesterol crystallization from lithogenic model bile by time-lapse density gradient ultracentrifugation. J Hepatol 26:703–710
Lammert F, Wang DQH, Hillebrandt S et al (2004) Spontaneous cholecysto-and hepatolithiasis in Mdr2-/-mice: a model for low phospholipid-associated cholelithiasis. Hepatology 39:117–128
Holzbach RT (1995) Cholesterol nucleation in bile. Ital J Gastroenterol Hepatol 27:101–105
Holzbach RT (1997) Newer pathogenetic concepts in cholesterol gallstone formation: a unitary hypothesis. Digestion 58 Suppl 1:29–32
Busch N, Matiuck N, Sahlin S et al (1991) Inhibition and promotion of cholesterol crystallization by protein factors from normal human gallbladder bile. J Lipid Res 32:695–702
Lee SM, LaMont JT, Carey MC (1981) Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones. Studies in the prairie dog. J Clin Invest 67:1712–1723
Afdhal NH, Gong D, Niu N et al (1993) Cholesterol cholelithiasis in the prairie dog: role of mucin and nonmucin glycoproteins. Hepatology 17:693–700
LaMont JT (1982) Gallbladder mucin glycoprotein hypersecretion in experimental cholelithiasis: role of mucin gel in nucleation of cholesterol gallstones. Adv Exp Med Biol 144:231–234
Levy PF, Smith BF, LaMont JT (1984) Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile. Gastroenterology 87:270–275
Lee SP, Nicholls JF (1986) Nature and composition of biliary sludge. Gastroenterology 90:677–686
Lee SP, Maher K, Nicholls JF (1988) Origin and fate of biliary sludge. Gastroenterology 94:170–176.
Carey MC, Cahalane MJ (1988) Whither biliary sludge. Gastroenterology 95:508–523
Wang HH, Afdhal NH, Gendler SJ et al (2004) Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation. J Lipid Res 45:438–447
Wittenburg H, Lammert F, Wang DQH et al (2002) Interacting QTLs for cholesterol gallstones and gallbladder mucin in AKR and SWR strains of mice. Physiol Genomics 8:67–77
Groen AK, Noordam C, Drapers JAG et al (1990) Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile of patients with solitary or multiple cholesterol gallstones. Hepatology 11:525–533
Hussaini SH, Pereira SP, Murphy GM et al (1995) Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile. Hepatology 22:1735–1744
Miquel JF, Nunez L, Amigo L et al (1998) Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile. Gastroenterology 114:1016–1023
Holzbach RT, Kibe A, Thiel E et al (1984) Biliary proteins: unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest 73:35–45
Kibe A, Holzbach RT (1984) Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile. Science 255:514–516
Secknus R, Darby GH, Chernosky A et al (1999) Apolipoprotein A-I in bile inhibits cholesterol crystallization and modifies transcellular lipid transfer through cultured human gall-bladder epithelial cells. J Gastroenterol Hepatol 14:446–456
Stolk MFJ, van de Heijning BJM, van Erpecum KJ et al (1994) The effect of bile acid hydrophobicity on nucleation of several types of cholesterol crystals from model bile vesicles. J Hepatol 20:802–810
van de Heijning BJM, Stolk MFJ, van Erpecum KJ et al (1994) The effects of bile salt hydrophobicity on model bile vesicle morphology. Biochim Biophys Acta 1212:203–210
van Erpecum KJ, Portincasa P, Stolk MFJ et al (1994) Effects of bile salt and phospholipid hydrophobicity on lithogenicity of human gallblader bile. Eur J Clin Invest 24:744–750
Portincasa P, Di Ciaula A, van Berge-Henegouwen GP (2004) Smooth muscle function and dysfunction in gallbladder disease. Curr Gastroenterol Rep 6:151–162
Portincasa P, Di Ciaula A, Baldassarre G et al (1994) Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation. J Hepatol 21:430–440
Moschetta A, Stolk MF, Rehfeld JF et al (2001) Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR. Aliment Pharmacol Ther 15:181–185
Wang DQH, Schmitz F, Kopin AS et al (2004) Targeted disruption of the murine cholecystokinin-1 recept or promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis. J Clin Invest 114:521–528
Sitzmann JV, Pitt HA, Steinborn PA et al (1990) Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet 170:25–31
Gebhard RL, Prigge WF, Ansel HJ et al (1996) The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss. Hepatology 24:544–548
Colecchia A, Sandri L, Bacchi-Reggiani ML et al (2003) Is it possible to predict the clinical course of gallstone disease? Usefulness of gallbladder motility evaluation in a clinical setting. Am J Gastroenterol 101:2576–2581
Portincasa P, Moschetta A, Baldassarre G et al (2003) Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting the Rome II criteria for irritable bowel. World J Gastroenterol 9:2293–2299
Portincasa P, Moschetta A, Berardino M et al (2004) Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults. world J Gastroenterol 10:2383–2390
Portincasa P, Moschetta A, Colecchia A et al (2003) Measurement of gallbladder motor function by ultrasonography: towards standardization. Dig Liver Dis (già Ital J Gastroenterol Hepatol) 35 (Suppl 3): S56–S61
Portincasa P, Di Ciaula A, Palmieri VO et al (1994) Sonographic evaluation of gallstone burden in humans. Ital J Gastroenterol Hepatol 26:141–144
Portincasa P, Di Ciaula A, Palmieri VO et al (1994) Enhancement of gallbladder emptying in gallstone patients after oral cholestyramine. Am J Gastroenterol 89:909–914
Portincasa P, Di Ciaula A, Palmieri VO et al (1995) Effects of cholestyramine on gallbladder and gastric emptying in obese and lean subjects. Eur J Clin Invest 25:746–753
Portincasa P, van Erpecum KJ, van de Meeberg PC et al (1996) Apolipoprotein (Apo) E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy. Hepatology 24:580–587
Portincasa P, Di Ciaula A, Palmieri VO et al (1996) Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects. Ital J Gastroenterol Hepatol 28:111–113
Portincasa P, Di Ciaula A, Palmieri VO et al (1997) Impaired gallbladder and gastric motility and pathological gastro-esophageal reflux in gallstone patients. Eur J Clin Invest 8:653–661
Portincasa P, Altomare DF, Moschetta A et al (2000) The effect of acute oral erythromycin on gallbladder motility and on upper gastrointestinal symptoms in gastrectomized patients with and without gallstones: a randomized, place bocontrolled ultrasonographic study. Am J Gastroenterol 95:3444–3451
Portincasa P, Di Ciaula A, Vendemiale G et al (2000) Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest 30:317–324
Portincasa P, Colecchia A, Di Ciaula A et al (2000) Standards for diagnosis of gastrointestinal motility disorders. Section: ultrasonography. A position statement from the Gruppo Italiano di Studio Motilita Apparato Digerente. Dig Liver Dis 32:160–172
Portincasa P, Moschetta A, Di Ciaula A et al (2001) Changes of gallbladder and gastric dynamics in patients with acute hepatitis A. Eur J Clin Invest 31:617–622
Stolk MFJ, van Erpecum KJ, Renooij W et al (1995) Gallbladder emptying in vivo, bile composition and nucleation of cholesterol crystals in patients with cholesterol gallstones. Gastroenterology 108:1882–1888
van Erpecum KJ, van Berge-Henegouwen GP, Stolk MFJ et al (1992) Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects. J Hepatol 14:194–202
Xiao ZL, Amaral J, Bianeani P et al (2005) Impaired cytoprotective function of muscle in human gallbladders with cholesterol stones. Am. J Physiol Gastrointest Liver Physiol 288:G525–G532
Di Magno EP, Hendricks JC, Go VLW et al (1979) (Relationships among canine fasting pancreatic and biliary secretions, pancreatic duct pressure, and duodenal phase III motor activity-Boldireff revisited. Dig Dis Sci 24:689–693
Stolk MFJ, van Erpecum KJ, Smout AJPM et al (1993) Motor cycles with phase III in antrum are associated with high motilin levels and prolonged galibladder emptying. Am J Physiol 264:G596–G600.
Stolk MF, van Erpecum KJ, Peeters TL et al (2001) Interdigestive gallbladder emptying, antroduodenal motility, and motilin release patterns are altered in cholesterol gallstone patients. Dig Dis Sci 46:1328–1334
van Erpecum KJ, Venneman NG, Portincasa P et al (2000) Agents affecting gall-bladder motility—role in treatment and prevention of gallstones (review). Aliment Pharmacol Ther 14 Suppl 2:66–70
Pauletzki JG, Althaus R, Holl J et al (1996) Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. Gastroenterology 111:765–771
Yu P, Chen Q, Biancani P et al (1996) Membrane cholesterol alters gallbladder muscle contractility in prairie dogs. Am J Physiol 271:G56–61
Xiao ZL, Chen Q, Amaral J et al (1999) CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. Am J Physiol 276:G1401–G1407
Yu P, De Petris G, Biancani P et al (1994) Cholecystokinin-coupled intracellular signaling in human gallbladder muscle. Gastroenterology 106:763–770
Yu P, Harnett KM, Biancani P et al (1994) Interaction between signal transduction pathways contributing to gallbladder tonic contraction. Am J Physiol 265:1082–1089
Yu P, Chen Q, Harnett KM et al (1995) Direct G protein activation reverses impaired CCK signaling in human gallbladders with cholesterol stones. Am J Physiol 269:G659–665
Yu P, Chen Q, Xiao Z et al (1998) Signal transduction pathways mediating CCK-induced gallbladder muscle contraction. Am J Physiol 275:G203–211
Portincasa P, Stolk MF, van Erpecum KJ et al (1995) Cholesterol gallstone formation in man and potential treatments of the gallbladder motility defect. Scand J Gastroenterol Suppl 212:63–78
van Erpecum KJ, Stolk MFJ, van den Broek AMWC et al (1993) Bile concentration promotes nucleation of cholesterol monobydrate crystals by increasing the cholesterol concentration in the vesicles. Eur J Clin Invest 23:283–288
Magnuson TH, Lillemoe KD, Zarkin BA et al (1992) Patients with uncomplicated cholelithiasis acidify bile normally. Dig Dis Sci 37:1517–1522
Calamita G, Ferri D, Bazzini C et al (2005) Expression and subcellular localization of the AQP8 and AQP1 water channels in the mouse gall-bladder epithelium. Biol Cell 97:415–423
Conter RL, Roslyn JJ, Porter-Fink V et al (1986) Gallbladder absorption increases during early cholesterol gallstone formation. Am J Surg 151:184–192
Ginanni Corradini S, Elisei W, Giovannelli L et al (2000) Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile. Gastroenterology 118:912–920
Einarsson C (1999) Lipid absorption by the human gallbladder. Ital J Gastroenterol Hepatol 31:571–573
Booker ML, Scott TE, LaMorte WW (1989) Effect of dietary cholesterol on phosphatidylcholines and phosphatidylethanolamines in bile and gallbladder mucosa in the prairie dog. Gastroenterology 97:1261–1267
Heaton KW, Emmett PM, Symes CL et al (1993) An explanation for gallstones in normal-weight women: slow intestinal transit. Lancet 341:8–10
van Erpecum KJ, van Berge-Henegouwen GP (1999) Gallstones: an intestinal disease? Gut 44:435–438
van Erpecum KJ, Wang DQH, Lammert F et al (2001) Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles. J Hepatol 35:444–451
Portincasa P, van Erpecum KJ, Jansen A et al (1996) Behavior of various cholesterol crystals in bile from gallstone patients. Hepatology 23:738–748
Shoda J, He BF, Tanaka N et al (1995) Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstones disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. Hepatology 21:1291–1302
Thomas LA, Veysey MJ, Murphy GM et al (2005) Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly. Gut 54:630–635
Thomas LA, Veysey MJ, Bathgate T et al (2000) Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis. Gastroenterology 119:806–815
Berr F, Kullak-Ublick GA, Paumgartner G et al (1996) Alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology 111:1611–1620
Pereira SP, Bain IM, Kumar D et al (2003) Bile composition in inflammatory bowel disease: ileal disease and colectomy, but not colitis, induce lithogenic bile. Aliment Pharmacol Ther 17:923–933
Brink MA, Slors JF, Keulemans YC et al (1999) Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn’s disease. Gastroenterology 116:1420–1427
Maurer KJ, Rogers AB, Ge Z et al (2006) Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: a prospective study. Am J Physiol Gastrointest Liver Physiol 290:G175–G182
Maurer KJ, Ihrig MM, Rogers AB et al (2005) Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 128:1023–1033
Fox JG, Dewhirst FE, Shen Z et al (1998) Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114:755–763
Moschetta A, Bookout AL, Mangelsdorf DJ (2004) Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 10:1352–1358
Wang HH, Wang DQH (2004) Overexpression of liver X receptor a (LXRa) enhance cholesterol (Ch) cholelithogenesis in gallstone-resistant AKR mice (abstract). Gastroenterology 126[4, Suppl. 2]: A15–110
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Italia
About this chapter
Cite this chapter
Portincasa, P. et al. (2008). Pathophysiology of Cholesterol Gallstone Disease. In: Biliary Lithiasis. Springer, Milano. https://doi.org/10.1007/978-88-470-0763-5_3
Download citation
DOI: https://doi.org/10.1007/978-88-470-0763-5_3
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0762-8
Online ISBN: 978-88-470-0763-5
eBook Packages: MedicineMedicine (R0)